OCTOBER 19, 2026
African Pharmaceutical Leaders Push for Stronger Action Against Falsified Medicines
Pharmaceutical industry leaders across Africa are calling for greater regional cooperation, stronger regulatory enforcement and improved medicine traceability to address the continued circulation of falsified and substandard pharmaceutical products.
The discussions were a central focus of the fourth Thematic General Assembly of the African Pharmaceutical Distribution Association (APDA), hosted in collaboration with the Pharmaceutical Wholesalers and Distributors Association of Nigeria (PWDAN) in Lagos from 6–8 October 2026.
Held under the theme Advancing Pharmaceutical Distribution in Africa: Building Secure Supply Chains Against Falsified Medicines, the gathering brought together pharmaceutical distributors, manufacturers, regulators and other industry stakeholders to examine how the continent can strengthen medicine distribution systems.
The discussions highlighted the importance of addressing weaknesses within pharmaceutical supply chains to protect patients and support the legitimate pharmaceutical trade.
The Importance of Secure Pharmaceutical Distribution
Effective pharmaceutical distribution plays a crucial role in ensuring that quality-assured medicines move safely from manufacturers to hospitals, pharmacies and healthcare providers.
However, weaknesses in product documentation, storage, transportation and distribution processes can create opportunities for falsified medicines to enter legitimate supply networks.
These challenges become more complex when pharmaceutical products move across multiple countries, each with different regulatory procedures and distribution requirements.
Industry representatives have emphasised that tackling the problem requires more than enforcement within individual markets. Stronger cooperation between national regulators, distributors and manufacturers is essential to improve oversight across borders.
In Nigeria, stakeholders have also called for the full implementation of the National Drug Distribution Guidelines to strengthen the structure and accountability of the country's pharmaceutical supply chain.
Traceability and Technology Are Becoming Increasingly Important
One of the key areas of discussion was the role of technology in improving pharmaceutical supply chain security.
Product identification, serialisation and authentication systems can help businesses verify the movement of medicines through distribution networks and identify potential weaknesses in supply processes.
Digital inventory management and improved documentation can also provide greater visibility for manufacturers, importers and wholesalers.
For pharmaceutical distributors, investment in stronger traceability systems may become an increasingly important part of maintaining regulatory compliance and building trust with international manufacturing partners.
Reliable supply chains are not only important for medicine safety. They also help legitimate businesses protect their commercial relationships and demonstrate their commitment to product quality.
Strengthening Partnerships Across Africa
As pharmaceutical trade continues to expand between African countries, the need for reliable and transparent distribution networks is becoming increasingly important.
Manufacturers entering new markets need confidence that their products will be handled appropriately, while distributors require dependable suppliers and clear regulatory requirements.
These priorities will remain central to conversations at Pharma West Africa 2027, where pharmaceutical businesses from across the international supply chain will come together to develop new partnerships and explore the changing African market.
The exhibition, supported by its industry conference, provides opportunities for manufacturers, wholesalers, importers and regulatory stakeholders to connect and address shared commercial challenges.
With the 2027 conference focusing on building a resilient and integrated pharmaceutical ecosystem, strengthening distribution standards and safeguarding medicine quality will remain particularly relevant industry priorities.
Join the pharmaceutical industry at Pharma West Africa, 13–15 April 2027, at the Landmark Centre, Lagos.